Clinical Trials on Amyloidosis Transthyretin
Total 544 results
-
Turkish Society of CardiologyRecruiting
-
Medical College of WisconsinTerminatedCardiac AmyloidosisUnited States
-
Brigham and Women's HospitalTerminatedCardiac AmyloidosisUnited States
-
University of MessinaCampisi MariapaolaUnknownCardiac AmyloidosisItaly
-
Tel-Aviv Sourasky Medical CenterUnknown
-
Tel-Aviv Sourasky Medical CenterUnknown
-
Seoul National University HospitalCW pharmaceutical companyUnknownCardiac AmyloidosisKorea, Republic of
-
Virginia Commonwealth UniversityNot yet recruitingAmyloidosis, HereditaryUnited States
-
Nanjing University School of MedicineRecruiting
-
Attralus, Inc.Novotech (Australia) Pty LimitedRecruitingAmyloidosis; SystemicUnited States, Australia, United Kingdom
-
Brigham and Women's HospitalRecruiting
-
University of Tennessee Graduate School of MedicineActive, not recruitingSystemic AmyloidosisUnited States
-
The Cleveland ClinicAvid RadiopharmaceuticalsTerminatedCardiac AmyloidosisUnited States
-
University Hospital Center of MartiniquePfizerUnknownCardiac AmyloidosisGuadeloupe, Martinique
-
University of EdinburghUnknown
-
Shahid Beheshti University of Medical SciencesCompleted
-
Air Force Military Medical University, ChinaNot yet recruitingImmunoglobulin Light-chain Amyloidosis
-
PETHEMA FoundationCompletedPrimary Systemic AmyloidosisSpain
-
National Cancer Institute (NCI)TerminatedPrimary Systemic AmyloidosisUnited States
-
Alnylam PharmaceuticalsCompletedTTR-mediated AmyloidosisUnited States, United Kingdom
-
Ionis Pharmaceuticals, Inc.Approved for marketingAmyloidosis, Hereditary
-
Alnylam PharmaceuticalsCompletedTTR-mediated AmyloidosisPortugal, Spain, Sweden, Brazil, United States, France, Germany
-
IRCCS Policlinico S. MatteoCompleted
-
Alnylam PharmaceuticalsCompleted
-
Alnylam PharmaceuticalsCompletedTTR-mediated AmyloidosisUnited Kingdom
-
Federico II UniversityEnrolling by invitation
-
Alnylam PharmaceuticalsCompletedTTR-mediated AmyloidosisPortugal, Sweden, Brazil, United States, France, Spain, Germany
-
Chulalongkorn UniversityRatchadapiseksompotch FundUnknownLichen AmyloidosisThailand
-
University Hospital, LimogesMinistry of Health, FranceCompletedPrimary Systemic Amyloidosis (AL)France
-
GCS Ramsay Santé pour l'Enseignement et la RechercheRecruiting
-
Wuhan Union Hospital, ChinaRecruiting
-
Attralus, Inc.CompletedAmyloidosis; SystemicUnited States
-
Seoul National University HospitalCompletedAmyloidosis CardiacKorea, Republic of
-
Boston Medical CenterSpectrum Pharmaceuticals, IncTerminatedAmyloidosis; SystemicUnited States
-
Mayo ClinicRecruitingHealthy Adults | Amyloidosis CardiacUnited States
-
Alnylam PharmaceuticalsCompletedTTR-mediated AmyloidosisUnited States, Canada, United Kingdom
-
Jin Lu, MDRecruitingAL Amyloidosis | Amyloidosis; SystemicChina
-
National Cancer Institute (NCI)CompletedPrimary Systemic Amyloidosis | Light Chain Deposition DiseaseUnited States
-
The Cleveland ClinicCompletedPrimary Systemic Amyloidosis
-
Sorrento Therapeutics, Inc.WithdrawnLight Chain (AL) Amyloidosis
-
Medical College of WisconsinNational Heart, Lung, and Blood Institute (NHLBI)CompletedPrimary Systemic AmyloidosisUnited States
-
Alnylam PharmaceuticalsTerminatedAmyloidosis | Leukocyte Chemotactic Factor 2 AmyloidosisUnited States, Malaysia, United Kingdom, Mexico, Egypt, India
-
Boston Medical CenterMillennium Pharmaceuticals, Inc.Completed
-
Istanbul UniversityCompleted
-
Sorrento Therapeutics, Inc.RecruitingLight Chain (AL) AmyloidosisUnited States
-
Weill Medical College of Cornell UniversityJanssen Scientific Affairs, LLCRecruitingAL Amyloidosis | Amyloid | Refractory AL AmyloidosisUnited States
-
IRCCS Policlinico S. MatteoTerminatedCardiac AL AmyloidosisSpain, France, Italy, Germany, Canada, Greece, Turkey, United Kingdom
-
Mayo ClinicCompletedPrimary Systemic AmyloidosisUnited States
-
University of LeipzigRecruiting